Page last updated: 2024-09-04

beta-lactams and lipoteichoic acid

beta-lactams has been researched along with lipoteichoic acid in 2 studies

Compound Research Comparison

Studies (beta-lactams)	Trials (beta-lactams)	Recent Studies (post-2010) (beta-lactams)	Studies (lipoteichoic acid)	Trials (lipoteichoic acid)	Recent Studies (post-2010) (lipoteichoic acid)
7,579	179	3,395	1,625	12	646

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Bootsma, HJ; Cobbaert, CM; de Vries, JJC; Groeneveld, GH; Joosten, SA; Kuijper, EJ; van der Reyden, TJ; van Dissel, JT	1
Alharbi, M; Alharbi, O; Biboy, J; Derrick, JP; Gallagher, LA; Grunert, T; Ingmer, H; Liu, H; Mayer, K; McBain, AJ; Mikkelsen, K; Nøhr-Meldgaard, K; O'Gara, JP; Sirisarn, W; Vestergaard, M; Vollmer, W; Xia, G	1

Trials

1 trial(s) available for beta-lactams and lipoteichoic acid

Article	Year
Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial. The Journal of antimicrobial chemotherapy, 2019, 08-01, Volume: 74, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Female; Humans; Inflammation; Lipopolysaccharides; Male; Middle Aged; Netherlands; Plasma; Pneumonia, Pneumococcal; Rifampin; Teichoic Acids; Treatment Outcome; Young Adult	2019

Article

Year

Non-lytic antibiotic treatment in community-acquired pneumococcal pneumonia does not attenuate inflammation: the PRISTINE trial.

The Journal of antimicrobial chemotherapy, 2019, 08-01, Volume: 74, Issue:8

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Community-Acquired Infections; Female; Humans; Inflammation; Lipopolysaccharides; Male; Middle Aged; Netherlands; Plasma; Pneumonia, Pneumococcal; Rifampin; Teichoic Acids; Treatment Outcome; Young Adult

2019

Other Studies

1 other study(ies) available for beta-lactams and lipoteichoic acid

Article	Year
The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate β-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids. International journal of antimicrobial agents, 2021, Volume: 57, Issue:3 Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cefoxitin; Cell Wall; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Larva; Lipopolysaccharides; Membrane Proteins; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Animal; Moths; Mutation; Octoxynol; Oxacillin; Penicillin-Binding Proteins; Peptidoglycan; Phenotype; Staphylococcal Infections; Teichoic Acids; Virulence	2021

Article

Year

The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate β-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids.

International journal of antimicrobial agents, 2021, Volume: 57, Issue:3

Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Cefoxitin; Cell Wall; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Larva; Lipopolysaccharides; Membrane Proteins; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Animal; Moths; Mutation; Octoxynol; Oxacillin; Penicillin-Binding Proteins; Peptidoglycan; Phenotype; Staphylococcal Infections; Teichoic Acids; Virulence

2021